ACTIVE

Geneeskundepraktijk Dokter Van Engeland- Dokter Vander Stuyft

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result120,8 k €+14,2 %over 1 year
Gross margin205,1 k €+16,2 %over 1 year
Equity630 k €+23,7 %over 1 year

Identity

Source · BCE/KBO

Geneeskundepraktijk Dokter Van Engeland- Dokter Vander Stuyft is a Private limited company incorporated in 1996. Its main activity is: General medical practice activities. Its registered office is in Sint-Katelijne-Waver.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0458.267.590
Incorporation
19/06/1996
Legal form
Private limited company
Registered office
Wilsonstraat 5
2860 Sint-Katelijne-Waver · FlandreSee on map
Contributed capital
1 592,01 €
Latest accounts
30/06/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin205,1 k €176,6 k €223 k €191,5 k €201,4 k €
EBITDA199,3 k €173,3 k €219,8 k €187,9 k €164 k €
Operating result170,7 k €146,2 k €190,9 k €159 k €131,7 k €
Net result120,8 k €105,8 k €139,5 k €45,3 k €96,3 k €
Balance sheet
Equity630 k €509,1 k €868,4 k €819,7 k €877,5 k €
Total assets693,4 k €711,4 k €1 M €926,1 k €946 k €
Cash375,2 k €380,6 k €74,3 k €181,7 k €359 k €
Debts63,4 k €202,2 k €153 k €106,4 k €68,5 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

2 active · 2 ended

Active mandates

Karel VAN ENGELANDT

Mandate

Active
Marleen VANDERSTUYFT

Mandate

Active

Ended mandates

Karel Van Engeland

Manager · since 11 juillet 1996

Ended
Marleen Vanderstuyft

Manager · since 11 juillet 1996

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date28/02/202631/01/202531/01/202431/01/202315/02/202229/01/2021
General meeting15/01/202601/12/202403/12/202304/12/202205/12/202112/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202515/01/202628/02/2026DutchPDF
Micro model30/06/202401/12/202431/01/2025DutchPDF
Micro model30/06/202303/12/202331/01/2024DutchPDF
Micro model30/06/202204/12/202231/01/2023DutchPDF
Micro model30/06/202105/12/202115/02/2022DutchPDF
Micro model30/06/202012/12/202029/01/2021DutchPDF
Micro model30/06/201901/12/201927/01/2020DutchPDF
Micro model30/06/201802/12/201822/01/2019DutchPDF
Micro model30/06/201703/12/201730/01/2018DutchPDF
Abridged model30/06/201604/12/201628/02/2017DutchPDF
Abridged model30/06/201515/01/201629/02/2016DutchPDF
Abridged model30/06/201415/01/201515/01/2015DutchPDF
Abridged model30/06/201301/12/201326/02/2014DutchPDF
Abridged model30/06/201201/12/201212/02/2013DutchPDF
Abridged model30/06/201130/12/201110/02/2012DutchPDF
Abridged model30/06/201031/12/201023/02/2011DutchPDF
Abridged model30/06/200928/12/200926/02/2010DutchPDF
Abridged model30/06/200830/12/200820/02/2009DutchPDF
Abridged model30/06/200710/12/200731/01/2008DutchPDF
Abridged model30/06/200610/01/200731/01/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

2 active · 2 ended

Active mandates

Karel VAN ENGELANDT

Mandate

Active
Marleen VANDERSTUYFT

Mandate

Active

Ended mandates

Karel Van Engeland

Manager · since 11 juillet 1996

Ended
Marleen Vanderstuyft

Manager · since 11 juillet 1996

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates10/01/2024
    WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025120,8 k €↑
  2. 2025
    Name changeGENEESK. VAN ENGELAND - VANDERSTUYF
  3. 2024
    Annual accounts 2024105,8 k €↓
  4. 2023
    Annual accounts 2023139,5 k €↑
  5. 2023
    Name changeGeneeskundepraktijk Dokter Van Engeland- Dokter Vander Stuyft
  6. 2022
    Annual accounts 202245,3 k €↓
  7. 2022
    Name changeGeneeskunde praktijk Dokter Van Engeland - Dokter Vanderstuyft
  8. 2021
    Annual accounts 202196,3 k €↑
  9. 2020
    Annual accounts 202019,7 k €↓
  10. 2019
    Annual accounts 2019179,2 k €↓
  11. 2018
    Annual accounts 2018205,1 k €↑
  12. 2017
    Annual accounts 2017174,3 k €↓
  13. 2016
    Annual accounts 2016235,8 k €↑
  14. 2015
    Annual accounts 2015161,9 k €↑
  15. 2014
    Annual accounts 201494,4 k €↓
  16. 2013
    Annual accounts 2013115,5 k €↓
  17. 2012
    Annual accounts 2012143,7 k €↑
  18. 2011
    Annual accounts 2011112,8 k €↑
  19. 2010
    Annual accounts 2010-9,1 k €↓
  20. 2009
    Annual accounts 200995,8 k €↓
  21. 2008
    Annual accounts 2008109,5 k €↑
  22. 2007
    Annual accounts 200762,2 k €
  23. 19/06/1996
    IncorporationPrivate limited company